1. Cancer Biology

Revised International Staging System (R-ISS) stage-dependent analysis uncovers oncogenes and potential immunotherapeutic targets in multiple myeloma

  1. Bo Gong  Is a corresponding author
  2. Ling Zhong
  3. Peng Hao
  4. Qian Zhang
  5. Tao Jiang
  6. Huan Li
  7. Jialing Xiao
  8. Chenglong Li
  9. Lan Luo
  10. Ping Shuai
  11. Liang Wang
  12. Yuping Liu
  13. Yi Shi
  14. Wei Zhang  Is a corresponding author
  1. University of Electronic Science and Technology of China, China
  2. Chengdu University of Traditional Chinese Medicine, China
https://doi.org/10.7554/eLife.75340
Share this article
Cite this article
  1. Bo Gong
  2. Ling Zhong
  3. Peng Hao
  4. Qian Zhang
  5. Tao Jiang
  6. Huan Li
  7. Jialing Xiao
  8. Chenglong Li
  9. Lan Luo
  10. Ping Shuai
  11. Liang Wang
  12. Yuping Liu
  13. Yi Shi
  14. Wei Zhang
(2022)
Revised International Staging System (R-ISS) stage-dependent analysis uncovers oncogenes and potential immunotherapeutic targets in multiple myeloma
eLife 11:e75340.
https://doi.org/10.7554/eLife.75340
  2. Download BibTeX
  3. Download .RIS

Abstract

Multiple myeloma (MM) accounts for ~10% of all haematologic malignancies. Little is known about high intratumour heterogeneities in patients stratified by the Revised International Staging System (R-ISS). Herein, we constructed a single-cell transcriptome atlas to compare differential expression patterns among stages. We found that a novel cytotoxic plasma cell (PC) population exhibited with NKG7 positive was obviously enriched in stage II patients. Additionally, a malignant plasma cell population with significantly elevated expression of MKI67 and PCNA was associated with unfavourable prognosis and Epstein-Barr virus (EBV) infection in our collected samples. Moreover, Ribonucleotide Reductase Regulatory Subunit M2 (RRM2) was found and verified to promote proliferation of MM cell lines, suggesting RRM2 may serve as a detrimental marker in MM. The percentages of CD8+ T cells and NKT cells decreased along with R-ISS stages, reflecting the plasticity of the tumour immune microenvironment. Importantly, their crosstalks with myeloid cells and PC identified several potential immunotargets such as SIRPA-CD47, and CD74-MIF, respectively. Collectively, this study provided an R-ISS-related single-cell MM atlas and revealed the clinical significance of novel PC clusters, as well as potential immunotargets in MM progression.

Data availability

Sequencing data have been deposited in GEO under accession code GSE176131.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Bo Gong

    Department of Health Management, University of Electronic Science and Technology of China, ChengDu, China
    For correspondence
    gongbo2007@hotmail.com
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2763-6829

  2. Ling Zhong

    Department of Health Management, University of Electronic Science and Technology of China, ChengDu, China
    Competing interests
    The authors declare that no competing interests exist.

  3. Peng Hao

    Department of Orthopaedics, University of Electronic Science and Technology of China, ChengDu, China
    Competing interests
    The authors declare that no competing interests exist.

  4. Qian Zhang

    Department of Health Management, University of Electronic Science and Technology of China, ChengDu, China
    Competing interests
    The authors declare that no competing interests exist.

  5. Tao Jiang

    Department of Hematology, University of Electronic Science and Technology of China, ChengDu, China
    Competing interests
    The authors declare that no competing interests exist.

  6. Huan Li

    Department of Health Management, University of Electronic Science and Technology of China, ChengDu, China
    Competing interests
    The authors declare that no competing interests exist.

  7. Jialing Xiao

    Department of Health Management, University of Electronic Science and Technology of China, ChengDu, China
    Competing interests
    The authors declare that no competing interests exist.

  8. Chenglong Li

    Department of Hematology, University of Electronic Science and Technology of China, ChengDu, China
    Competing interests
    The authors declare that no competing interests exist.

  9. Lan Luo

    Chengdu University of Traditional Chinese Medicine, Chengdu, China
    Competing interests
    The authors declare that no competing interests exist.

  10. Ping Shuai

    Department of Health Management, University of Electronic Science and Technology of China, ChengDu, China
    Competing interests
    The authors declare that no competing interests exist.

  11. Liang Wang

    Department of Health Management, University of Electronic Science and Technology of China, ChengDu, China
    Competing interests
    The authors declare that no competing interests exist.

  12. Yuping Liu

    Department of Health Management, University of Electronic Science and Technology of China, ChengDu, China
    Competing interests
    The authors declare that no competing interests exist.

  13. Yi Shi

    Department of Health Management, University of Electronic Science and Technology of China, ChengDu, China
    Competing interests
    The authors declare that no competing interests exist.

  14. Wei Zhang

    Department of Orthopaedics, University of Electronic Science and Technology of China, ChengDu, China
    For correspondence
    zhangwspine@163.com
    Competing interests
    The authors declare that no competing interests exist.

Funding

National Natural Science Foundation of China (Youth Funds,82002212)

  • Ling Zhong

Science & Technology Department of Sichuan Province (Applied Basic Research,2022YFS0100)

  • Peng Hao

Chengdu Science and Technology Bureau (Applied Basic Research,2019-YF05-00572-SN)

  • Ling Zhong

China Postdoctoral Science Foundation (general program，2019M663567)

  • Ling Zhong

UESTC (Basic scientific research,ZYGX2020J024)

  • Ling Zhong

UESTC (Medicine-engineering interdisciplinary,ZYGX2021YGLH006)

  • Ling Zhong

Science &Technology Department of Sichuan Province (Outstanding Youth Fund，2022JDTD0024)

  • Bo Gong

Chengdu Science and Technology Bureau (Applied Basic Research,2022-YF05-01625-SN)

  • Bo Gong

Sichuan cadre health care project (Sichuan cadre health care project,2022-216)

  • Wei Zhang

UESTC (Medicine-engineering interdisciplinary,ZYGX2021YGLH204)

  • Wei Zhang

The roles of the funders were to do single cell sequence, analysis data, and verify the conclusions.

Ethics

Human subjects: Written informed consents were obtained from all subjects. All experimental procedures were approved by the Medical ethics committee of Sichuan Provincial People's Hospital and carried out in accordance with the principles of the Declaration of Helsinki. ALL of the patients signed the informed consent containing contact Information, the purpose of the study, risks and benefits from this study, consent to publish the manuscript. The protocol numbers was 2020-240.

Copyright

© 2022, Gong et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,159
    views
  • 158
    downloads
  • 6
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Bo Gong
  2. Ling Zhong
  3. Peng Hao
  4. Qian Zhang
  5. Tao Jiang
  6. Huan Li
  7. Jialing Xiao
  8. Chenglong Li
  9. Lan Luo
  10. Ping Shuai
  11. Liang Wang
  12. Yuping Liu
  13. Yi Shi
  14. Wei Zhang
(2022)
Revised International Staging System (R-ISS) stage-dependent analysis uncovers oncogenes and potential immunotherapeutic targets in multiple myeloma
eLife 11:e75340.
https://doi.org/10.7554/eLife.75340

Share this article

https://doi.org/10.7554/eLife.75340

Categories and tags

Research organism

Further reading

    1. Cancer Biology
    2. Cell Biology

    Changes in local mineral homeostasis facilitate the formation of benign and malignant testicular microcalcifications

    Ida Marie Boisen, Nadia Krarup Knudsen ... Martin Blomberg Jensen
    Research Article

    Testicular microcalcifications consist of hydroxyapatite and have been associated with an increased risk of testicular germ cell tumors (TGCTs) but are also found in benign cases such as loss-of-function variants in the phosphate transporter SLC34A2. Here, we show that fibroblast growth factor 23 (FGF23), a regulator of phosphate homeostasis, is expressed in testicular germ cell neoplasia in situ (GCNIS), embryonal carcinoma (EC), and human embryonic stem cells. FGF23 is not glycosylated in TGCTs and therefore cleaved into a C-terminal fragment which competitively antagonizes full-length FGF23. Here, Fgf23 knockout mice presented with marked calcifications in the epididymis, spermatogenic arrest, and focally germ cells expressing the osteoblast marker Osteocalcin (gene name: Bglap, protein name). Moreover, the frequent testicular microcalcifications in mice with no functional androgen receptor and lack of circulating gonadotropins are associated with lower Slc34a2 and higher Bglap/Slc34a1 (protein name: NPT2a) expression compared with wild-type mice. In accordance, human testicular specimens with microcalcifications also have lower SLC34A2 and a subpopulation of germ cells express phosphate transporter NPT2a, Osteocalcin, and RUNX2 highlighting aberrant local phosphate handling and expression of bone-specific proteins. Mineral disturbance in vitro using calcium or phosphate treatment induced deposition of calcium phosphate in a spermatogonial cell line and this effect was fully rescued by the mineralization inhibitor pyrophosphate. In conclusion, testicular microcalcifications arise secondary to local alterations in mineral homeostasis, which in combination with impaired Sertoli cell function and reduced levels of mineralization inhibitors due to high alkaline phosphatase activity in GCNIS and TGCTs facilitate osteogenic-like differentiation of testicular cells and deposition of hydroxyapatite.

    1. Cancer Biology

    TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis

    Qianqian Ju, Wenjing Sheng ... Cheng Sun
    Research Article

    TAK1 is a serine/threonine protein kinase that is a key regulator in a wide variety of cellular processes. However, the functions and mechanisms involved in cancer metastasis are still not well understood. Here, we found that TAK1 knockdown promoted esophageal squamous cancer carcinoma (ESCC) migration and invasion, whereas TAK1 overexpression resulted in the opposite outcome. These in vitro findings were recapitulated in vivo in a xenograft metastatic mouse model. Mechanistically, co-immunoprecipitation and mass spectrometry demonstrated that TAK1 interacted with phospholipase C epsilon 1 (PLCE1) and phosphorylated PLCE1 at serine 1060 (S1060). Functional studies revealed that phosphorylation at S1060 in PLCE1 resulted in decreased enzyme activity, leading to the repression of phosphatidylinositol 4,5-bisphosphate (PIP2) hydrolysis. As a result, the degradation products of PIP2 including diacylglycerol (DAG) and inositol IP3 were reduced, which thereby suppressed signal transduction in the axis of PKC/GSK-3β/β-Catenin. Consequently, expression of cancer metastasis-related genes was impeded by TAK1. Overall, our data indicate that TAK1 plays a negative role in ESCC metastasis, which depends on the TAK1-induced phosphorylation of PLCE1 at S1060.

    1. Cancer Biology
    2. Cell Biology

    Breast Cancer: How cell crowding causes cancer cells to spread

    Rui Hua, Jean X Jiang
    Insight

    Cell crowding causes high-grade breast cancer cells to become more invasive by activating a molecular switch that causes the cells to shrink and spread.